Guisen Zhang

Guisen Zhang

Auto-generated profile, based on publicly available information

Guisen Zhang

Department of Ophthalmology, Hohhot Chao Ju Eye Hospital, Hohhot 010000, People's Republic of China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
JZJie Zhang
Jie Zhang
JJJinghua Jiao
Jinghua Jiao
MNMeng Niu
Meng Niu
XGXiaotong Gao
Xiaotong Gao
GZGuisen Zhang
Guisen Zhang
LLLei Liu
Lei Liu
The complex drug delivery barrier in the eye reduces the bioavailability of many drugs, resulting in poor therapeutic effects. It is necessary to investigate new drugs through appropriate delivery routes and vehicles. Nanotechnology has utilized various nano-carriers to develop potential ocular drug delivery techniques that interact with the ocular mucosa, prolong the retention time of drugs in the eye, and increase permeability. Additionally, nano-carriers such as liposomes, nanoparticles, nano-suspensions, nano-micelles, and nano-emulsions have grown in popularity as an effective theranostic application to combat different microbial superbugs. In this review, we summarize the nano-carrier based drug delivery system developments over the last decade, particularly review the biology, methodology, approaches, and clinical applications of nano-carrier based drug delivery system in the field of ocular therapeutics. Furthermore, this review addresses upcoming challenges, and provides an outlook on potential future trends of nano-carrier-based drug delivery approaches in ophthalmology, and hopes to eventually provide successful applications for treating ocular diseases.

23 November 2019 in Disease Markers
Verified
Journal Article
Open access
PDF file
JWJingyang Wu
Jingyang Wu
YZYifan Zhong
Yifan Zhong
SYSong Yue
Song Yue
KYKaibo Yang
Kaibo Yang
GZGuisen Zhang
Guisen Zhang
LLLei Liu
Lei Liu
Purpose. To evaluate the relationship between the aqueous humor levels of VEGF, TNF-α, IL-10, IL-6, IL-12, MCP-1, and IP-10 with DR/DME. Methods. PubMed, Web of Science, Embase, China National Knowledge Infrastructure (CNKI), and Wanfang databases were searched up to October 2018. Systematic review and meta-analysis were conducted. Results. 18 studies comprising 362 cases with DR (100 with DME) and 620 controls without DR were included in this meta-analysis. There was a significant association between VEGF levels in the aqueous humor and DR (standardized mean difference (SMD) 1.94 (95% CI 1.05-2.83)) and DME (1.07 (0.71, 1.42)). Furthermore, a significant correlation was observed between levels of IL-6 and DR (3.53 (0.37, 6.69)), and similarly correlation with DME (1.26 (0.30, 2.21)). The relationship between MCP-1 and DR and DME was significant, in which the SMD was (0.49 (0.09, 0.89)) and (1.49 (0.78, 2.20)), respectively. However, IL-12, IP-10, and TNF-α had no correlation with DR and DME, whereas there was a significant relationship between IL-8 and DME (1.68 (0.97, 2.40)). Conclusion. Elevated levels of VEGF, IL-6, and MCP-1 in the aqueous humor were associated with the risk for the presence of DR, and levels of VEGF, IL-6, IL-8, and MCP-1 were associated with the risk of DME. Furthermore, these biomarkers may be used as potential predictors or therapeutic targets for DR/DME.

1 September 2019 in Diabetes, Metabolic Syndrome and Obesity
Verified
Journal Article
Open access
PDF file
LYLitong Yao
Litong Yao
YZYifan Zhong
Yifan Zhong
JWJingyang Wu
Jingyang Wu
GZGuisen Zhang
Guisen Zhang
LCLei Chen
Lei Chen
LLLei Liu
Lei Liu
Background: Monitoring and prediction of diabetic retinopathy (DR) is necessary in patients with diabetes for early discovery and timely treatment of disease. We aimed to analyze the association between DR and biochemical and metabolic parameters, and develop a predictive model for DR. Methods: A total of 530 Chinese residents including 423 with type 2 diabetes (T2D) aged 18 years or older participated in this study. The association between DR and biochemical and metabolic parameters was analyzed by the univariate and multivariable logistic regression (MLR). According to the MLR results, we developed a back propagation artificial neural network (BP-ANN) model by selecting tan-sigmoid as the transfer function of the hidden layers nodes, and pure-line of the output layer nodes, with training goal of 0.5×10−5. Results: There were 51 (9.6%) diabetic participants with DR. After univariate and MLR analysis, duration of diabetes, waist to hip ratio, HbA1c and family history of diabetes were independently associated with the presence of DR (all P < 0.05). Based on these parameters, the area under the receiver operating characteristic (ROC) curve for the BP-ANN model was significantly higher than that by MLR (0.84 vs. 0.77, P < 0.001). Conclusion: Our evaluation demonstrated the potential role of BP-ANN model to identify DR in screening practice. The presence of DR was well predictable using the proposed BP-ANN model based on four related parameters (duration of diabetes, waist to hip ratio, HbA1c and family history of diabetes).

1 March 2019 in Medicine
Verified
Journal Article
Open access
SZShan Zhao
Shan Zhao
XLXiaowen Lan
Xiaowen Lan
JWJingyang Wu
Jingyang Wu
SYSong Yue
Song Yue
HZHan Zhang
Han Zhang
LLLei Liu
Lei Liu
Background: There have been many reports on the prevalence and incidence of age-related macular degeneration (AMD), and there are some systematic reviews reporting on the pooled prevalence of AMD. However, there is no systematic review of incidence or progression of AMD worldwide. Given the few evidences regarding the pooled incidence or progression of AMD, we performed this meta-analysis protocol to investigate the global incidence or progression of AMD. In addition, we will investigate the risk factors for AMD incidence or progression using meta-analysis. Methods: Four English databases (PubMed, EMBASE, Cochrane Library, and Web of Science) and four Chinese databases (CMB, CNKI, VIP, and Wanfang database) will be searched to identify relevant studies. The primary outcome of this meta-analysis is the incidence or progression of AMD. The second outcome of this meta-analysis is risk factors for the incidence or progression of AMD. Meta-analysis was performed to calculate the pooled incidence or progression rate and 95% confidence interval of AMD. Pooled risk ratios of risk factors (age, gender, smoking, and hypertension) for AMD incidence or progression were computed as the Mantel–Haenszel-weighted average of the risk ratios for all included studies. Sensitivity analysis, subgroup analysis, quality assessment, and publication bias analysis will be performed to ensure the reliability of our findings. Results: This study will provide a current evidence of global pooled incidence or progression of AMD. Further, current study will provide evidence-based risk factors for AMD incidence or progression. Moreover, our study will project the incident number of people with AMD from 2030 to 2050. Conclusion: This systematic review and meta-analysis will provide evidence to develop major public health strategies for preventing AMD. Ethics and dissemination: ethical approval is not required because our systematic review and meta-analysis will be based on published data without interventions on patients. The findings of this study will be published in a peer-reviewed journal.

25 November 2021 in Frontiers in Medicine
Verified
Journal Article
Open access
JWJianhua Wu
Jianhua Wu
XWXiaomei Wu
Xiaomei Wu
HZHan Zhang
Han Zhang
XZXiaoguang Zhang
Xiaoguang Zhang
JZJie Zhang
Jie Zhang
LLLei Liu
Lei Liu
Purpose: Dry eye disease (DED) is projected to have increasing public health burden in China with the aging population. No published studies on the epidemiology of DED have been found in grasslands. We estimated DED prevalence among older adults living in grasslands of northern China and investigated its associated factors and impact on vision-related quality of life (VR-QoL).Methods: A multistage cluster random sampling technique was used to select Mongolian and Han participants aged over 40 from November 2020 to May 2021 in this area. An assessment of DED was performed with Ocular Surface Disease Index (OSDI) questionnaire, Schirmer's I test (ST), and Tear film break up time (TBUT). All the participants completed the Chinese version of National Eye Institute Visual Function Questionnaire (NEI-VFQ-25) assessing VR-QoL.Results: Of the 1,400 enumerated residents, 1,287 were examined. The overall age and gender standardized prevalence of DED was 34.5%, of which, 32.6% of Mongolian and 35.4% of Han had DED. In a multivariate model, statistically significant associations were found with advancing age [odds ratio (OR) 1.03, 95% confidence interval (CI) 1.02–1.04], female gender (OR 1.32, 95% CI 1.04–1.68), smoking (OR 0.7, 95% CI 0.5–0.98), anti-fatigue eye-drop use (OR 0.56, 95% CI 0.41–0.77), milk product intake (OR 0.55, 95% CI 0.39–0.77), number of household members (OR 0.8, 95% CI 0.72–0.88). DED was associated with lower scores on VR-QoL (β= −0.14, P < 0.01). Similar results were observed when analyses were stratified by ethnicity.Conclusions: The novelty-associated factors for DED in the grasslands area were anti-fatigue eye drop use, milk product intake, and number of household members. DED and its components were associated with VR-QoL. Further prospective studies are needed to confirm these findings.

1 April 2019 in Diabetes, Metabolic Syndrome and Obesity
Verified
Journal Article
Open access
PDF file
JWJingyang Wu
Jingyang Wu
YZYifan Zhong
Yifan Zhong
SYSong Yue
Song Yue
PGPeng Guan
Peng Guan
GZGuisen Zhang
Guisen Zhang
LCLei Chen
Lei Chen
Purpose: Abnormal levels of lipid accumulation product (LAP) have been associated with risk of cardiovascular disease and diabetes. However, it is not clear whether LAP index is associated with diabetic retinopathy (DR). We investigated the association between LAP index and DR in Chinese adults with diabetes. Patients and methods: We included 427 Chinese patients with type 2 diabetes aged 18-year over who participated in a community-based cross-sectional study in Shenyang. DR was addressed on retinal photographs graded using the modified Airlie House classification. LAP was defined as (waist circumference [cm]–65) × (triglycerides [mmol/L]) in men, and (waist circumference [cm]–58) × (triglycerides [mmol/L]) in women and analyzed continuously (per SD change) and categorically (quartile 1, 50). Results: Prevalence of DR among the study population was 17.8%. The mean level of LAP was 52.96±44.01. Compared to quartile 1 level, both quartile 2 and 3 levels were associated with DR with multivariable odds ratio (95% CI) of 0.23 (0.12–0.46) and 0.27 (0.14–0.54), respectively. These associations persisted when LAP was analyzed continuously (0.57 [0.35–0.92]). Conclusion: Higher central lipid accumulation in Chinese diabetics is related to the lower risk of DR, suggesting that LAP may be useful for identifying type 2 diabetes mellitus patients who are at risk for DR.